TCR-NK: A Novel Treatment Paradigm For The Treatment of Solid Cancer

Time: 10:45 am
day: Day 2 - Track A - Morning


  • TCR-NK is a novel treatment paradigm that brings together the well validated solid tumour targeting mechanism of T-Cell Receptors (TCRs) with the pan cancer recognition and highly potent activity of Natural Killer Cells (NKs)
  • We show the polyfunctionality of TCR-NKs triggered by both the high specificity of TCRs as well as pan cancer innate NK recognition resulting in activity against various cancers with the potential to overcome tumour heterogeneity
  • We are developing a platform to deliver a pipeline of novel TCR-NK therapies for the treatment of solid cancers